​

MetLife (MET) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MET Stock Forecast

MetLife (MET) stock forecast, based on 32 Wall Street analysts, predicts a 12-month average price target of $95.00, with a high of $102.00 and a low of $84.00. This represents a 23.10% increase from the last price of $77.17.

$65 $73 $81 $89 $97 $105 High: $102 Avg: $95 Low: $84 Last Closed Price: $77.17

MET Stock Rating

MetLife stock's rating consensus is Buy, based on 32 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 25 Buy (78.12%), 7 Hold (21.88%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 32 0 7 25 Strong Sell Sell Hold Buy Strong Buy

MET Price Target Upside V Benchmarks

TypeNameUpside
StockMetLife23.10%
SectorFinancial Services Stocks 5.28%
IndustryLife Insurance Stocks 14.89%

Price Target Trends

1M3M12M
# Anlaysts5714
Avg Price Target$96.00$97.43$96.93
Last Closing Price$77.17$77.17$77.17
Upside/Downside24.40%26.25%25.61%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 26395--17
Dec, 25485--17
Nov, 25484-117
Oct, 25484-117
Sep, 25573-116
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 14, 2026Mizuho Securities$102.00$77.0832.33%32.18%
Jan 13, 2026Elyse GreenspanWells Fargo$97.00$78.3223.85%25.70%
Jan 08, 2026UBS$94.00$79.7917.81%21.81%
Jan 08, 2026Barclays$90.00$79.4713.25%16.63%
Jan 06, 2026Evercore ISI$97.00$81.7718.63%25.70%
Dec 15, 2025Mizuho Securities$101.00$82.6222.25%30.88%
Dec 15, 2025Morgan Stanley$101.00$83.2221.37%30.88%
Oct 08, 2025Barclays$98.00$82.7518.43%26.99%
Oct 07, 2025Bob HuangMorgan Stanley$97.00$82.7017.29%25.70%
Sep 19, 2025John BarnidgePiper Sandler$84.00$79.076.23%8.85%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 13, 2026Wells FargoOverweightOverweighthold
Dec 15, 2025Morgan StanleyOverweightOverweighthold
Oct 08, 2025BarclaysOverweightOverweighthold
Oct 07, 2025Morgan StanleyOverweightOverweighthold
Sep 15, 2025Wolfe ResearchOutperformOutperforminitialise
Aug 22, 2025Cowen & Co.BuyBuyhold
Jul 14, 2025Morgan StanleyOverweightOverweighthold
Jul 10, 2025Wells FargoOverweightOverweighthold
May 06, 2025Wells FargoOverweightOverweighthold
Apr 02, 2025Piper SandlerOverweightOverweighthold

Financial Forecast

EPS Forecast

$0 $3 $6 $9 $12 $15 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$7.36$2.93$1.81$6.33---
Avg Forecast$8.47$6.95$7.31$8.21$9.61$10.74$11.96
High Forecast$8.83$7.23$7.44$8.33$9.86$11.56$13.81
Low Forecast$8.14$6.70$7.11$8.02$9.36$8.49$8.58
Surprise %-13.11%-57.84%-75.24%-22.90%---

Revenue Forecast

$65B $69B $73B $77B $81B $85B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$71.08B$69.90B$66.41B$70.99B---
Avg Forecast$67.68B$77.30B$71.42B$72.81B$76.54B$79.69B$83.81B
High Forecast$69.88B$79.77B$72.37B$74.27B$79.27B$79.73B$83.81B
Low Forecast$65.63B$75.22B$70.70B$71.50B$74.72B$79.64B$83.81B
Surprise %5.02%-9.58%-7.01%-2.51%---

Net Income Forecast

$1B $3B $5B $7B $9B $11B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$6.86B$2.35B$1.58B$4.43B---
Avg Forecast$3.87B$2.40B$1.38B$6.23B$7.33B$7.64B$6.60B
High Forecast$4.64B$2.88B$1.66B$6.35B$7.52B$8.81B$10.52B
Low Forecast$3.10B$1.92B$1.10B$6.12B$7.14B$6.47B$6.54B
Surprise %77.11%-1.76%14.35%-28.98%---

MET Forecast FAQ

Is MetLife stock a buy?

MetLife stock has a consensus rating of Buy, based on 32 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 25 Buy, 7 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that MetLife is a favorable investment for most analysts.

What is MetLife's price target?

MetLife's price target, set by 32 Wall Street analysts, averages $95 over the next 12 months. The price target range spans from $84 at the low end to $102 at the high end, suggesting a potential 23.10% change from the previous closing price of $77.17.

How does MetLife stock forecast compare to its benchmarks?

MetLife's stock forecast shows a 23.10% upside, outperforming the average forecast for the financial services stocks sector (5.28%) and outperforming the life insurance stocks industry (14.89%).

What is the breakdown of analyst ratings for MetLife over the past three months?

  • January 2026: 17.65% Strong Buy, 52.94% Buy, 29.41% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 23.53% Strong Buy, 47.06% Buy, 29.41% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 23.53% Strong Buy, 47.06% Buy, 23.53% Hold, 0% Sell, 5.88% Strong Sell.

What is MetLife’s EPS forecast?

MetLife's average annual EPS forecast for its fiscal year ending in December 2025 is $9.61, marking a 51.82% increase from the reported $6.33 in 2024. Estimates for the following years are $10.74 in 2026, and $11.96 in 2027.

What is MetLife’s revenue forecast?

MetLife's average annual revenue forecast for its fiscal year ending in December 2025 is $76.54B, reflecting a 7.83% increase from the reported $70.99B in 2024. The forecast for 2026 is $79.69B, and $83.81B for 2027.

What is MetLife’s net income forecast?

MetLife's net income forecast for the fiscal year ending in December 2025 stands at $7.33B, representing an 65.58% increase from the reported $4.43B in 2024. Projections indicate $7.64B in 2026, and $6.6B in 2027.